Uncategorized

Edgewise Therapeutics, Inc. today announced the pricing of an underwritten offering of 21,818,182 shares of its common stock at an offering price of $11.00 per share.

Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, has signed a collaboration agreement for DiviTum® TKa in Spain and Portugal with the Palex Group, a leading hospital equipment supplier with a proven track record in taking oncology tests and surgical instruments to market in southern Europe.

Mergers and acquisitions increased last year as health systems sought strong partners while expanding capabilities in “core” markets, the consultancy said.

The Minneapolis-based nonprofit will launch a nationwide search for a successor to Ric Magnuson, who has served Allina for over 25 years.

It’s not yet clear how much the new Medicaid managed care contract is worth. The state’s previous contract with insurers, including Centene, allocated $6 billion in funds over five years.

RBC Capital Markets analysts predict Volt could launch in the U.S. as early as 2026.

More than 150 health systems, hospitals and medical centers will deploy the Dragon Ambient eXperience Copilot embedded within Epic, the Microsoft-owned company said.

In a joint letter Thursday, leaders from the agencies outlined why they are opposed to using the Clinical Laboratory Improvement Amendments to address concerns with LDTs.

Whether this year’s crop of IPOs—Alto Neuroscience, ArriVent Biopharma, CG Oncology, Kyverna Therapeutics and Metagenomi—will trade below their offering prices remains to be seen.

En la lucha global contra el cambio climático, la tecnología de captura y almacenamiento de carbono (CAC) se ha destacado como una estrategia crucial para reducir las emisiones de dióxido de carbono (CO2). Sin embargo, la práctica de almacenar CO2 bajo tierra ha suscitado …